Adriatic region
Croatia, Bosnia-Herzegovina, Serbia and Slovenia
AER
Actual Exchange Rate
API
Active Pharmaceutical Ingredient
APM
Alternative Performance Measures
BEPS
Base Erosion Profit Sharing
Bioequivalence
The demonstration that the proposed formulation has the same biological effects as the pioneer product to which it is being compared. This is usually demonstrated by comparing blood concentrations of the active over time, but can be compared using a clinical endpoint (e.g. lowering of a worm count) for drugs that are not absorbed or for which blood levels cannot be determined
bps
Basis Points
CAGR
Compound Annual Growth Rate
CAP
Companion Animal Products
CER
Constant Exchange Rate
CMOs
Contract Manufacturing Organisations
CMO
Contract Manufacturing Organisations
CPD
Continuing Professional Development
CRM
Customer Relationship Management
CSOP
Company Share Option Plan
CTR
Clinical Trials Required
Dechra Values or Values
Dedication, Enjoyment, Courage, Honesty, Relationships and Ambition
Values
Dedication, Enjoyment, Courage, Honesty, Relationships and Ambition
DPM
Dechra Pharmaceuticals Manufacturing
DSC
Dechra Service Center
DVP
Dechra Veterinary Products
DVP EU
Dechra Veterinary Products EU or Dechra Veterinary Products Europe
DVP International
Dechra Veterinary Products International
DVP NA
Dechra Veterinary Products North America
DVP US
Dechra Veterinary Products US
EBIT
Earnings before interest and tax. This is the same as non-underlying operating profit
EBITDA
Earnings before interest, tax, depreciation and amortisation
EPS
Earnings Per Share
ERP
Enterprise Resource Planning
ETR
Effective Tax Rate
EU Pharmaceuticals
European Pharmaceuticals Segment comprising DVP EU, DVP International and DPM and Apex
European Pharmaceuticals
European Pharmaceuticals Segment comprising DVP EU, DVP International and DPM and Apex
Executive Directors
The Executive Directors of the Company, currently Ian Page, Richard Cotton and Tony Griffin
FAP
Food producing Animal Products
FDA
US Food and Drug Administration; a federal agency of the US Department of Health and Human Services
FRC
Financial Reporting Council
FRS
Financial Reporting Standards
FTSE
Companies listed on the London Stock Exchange
FTSE100 Index
An index comprising the 1st to 100th largest companies listed on the London Stock Exchange in terms of their market capitalisation
FTSE250/350 Index
An index comprising the 101st to 350th largest companies listed on the London Stock Exchange in terms of their market capitalisation
FTSE 250
An index comprising the 101st to 350th largest companies listed on the London Stock Exchange in terms of their market capitalisation
GAAP
Generally Accepted Accounting Practices
GHG
Greenhouse Gas
GMP
Good Manufacturing Practice
HALMED
Agency for Medicinal Products and Medicinal Devices of Croatia
HR
Human Resources
IAS
International Accounting Standards
IFRSs
International Financial Reporting Standards
IT
Information Technology
KPI
Key Performance Indicator
LIBOR
The London Inter-Bank Offered Rate
LTAFR
Lost Time Accident Frequency Rate
LTIP
Long Term Incentive Plan
MAT
Moving Annual Total
MHRA
Medicines and Healthcare products Regulatory Agency; an executive agency of the Department of Health in the UK
Maximum Residue Limit (MRL)
The maximum acceptable concentration of a substance that may be found in a food product obtained from an animal that has received a veterinary medicine
NADA
New Animal Drug Application
Non-Executive Directors
The Non-Executive Directors of the Company, currently Tony Rice, Julian Heslop, Lawson Macartney and Ishbel Macpherson
North America Pharmaceuticals
North American Pharmaceuticals Segment comprising DVP US and Canada and Dechra-Brovel
North American Pharmaceuticals
North American Pharmaceuticals Segment comprising DVP US and Canada and Dechra-Brovel
North American Segment
North American Pharmaceuticals Segment comprising DVP US and Canada and Dechra-Brovel
NA Pharmaceuticals
North American Pharmaceuticals Segment comprising DVP US and Canada and Dechra-Brovel
OECD
The Organisation for Economic Cooperation and Development
Ordinary Shares
An ordinary share of 1 pence in the share capital of the Company
Oracle Programme
Enterprise Resources Planning (ERP) software
POMs
Prescription Only Medicines
PDRA
Dechra's Product Development and Regulatory Affairs team
Qualifying LTIP Award
Qualifying LTIP Awards comprises a CSOP option and an ordinary nil-cost LTIP award, with the ordinary award scaled back at exercise to take account of any gain made on exercise of the CSOP option.
R&D
Research and Development
RCF
Revolving Credit Facility
RIDDOR
Reporting of Injuries, Diseases and Dangerous Occurrences Regulations
Rights Issue
The three for ten rights issue of 20,040,653 shares, details of which are set out in the prospectus of the Company dated 25 April 2012
ROCE
Return On Capital Employed
RPI
Retail Price Index
SAYE
Save As You Earn Share Scheme
SET
Senior Executive Team
SG&A
Selling, General and Administrative Expenses
SKU's
Stock Keeping Units
TSR
Total Shareholder Return
VMD
Veterinary Medicines Directorate